Newron Pharmaceuticals SpA Cash Flow Conversion Efficiency

Latest as of December 2025: 0.119x

Newron Pharmaceuticals SpA cash flow conversion efficiency. Based on the latest financial reports, Newron Pharmaceuticals SpA (NWRN) has a cash flow conversion efficiency ratio of 0.119x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-1.33 Million ≈ $-1.68 Million USD) by net assets (CHF-11.13 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Newron Pharmaceuticals SpA (2005–2025)

Cash flow conversion efficiency of Newron Pharmaceuticals SpA from 2005 to 2025. This chart illustrates how Newron Pharmaceuticals SpA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Newron Pharmaceuticals SpA (NWRN) share price today for real-time trading data and today's change.

Newron Pharmaceuticals SpA Cash Flow Conversion Ratio Explained

Newron Pharmaceuticals SpA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Newron Pharmaceuticals SpA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Newron Pharmaceuticals SpA ranked by their cash flow conversion efficiency. Also see NWRN market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Launchpad Cadenza Acquisition Corp I Class A Ordinary Share NASDAQ:LPCV	-0.001x
Chongqing Wanli New Energy Co Ltd SHG:600847	-0.029x
Ningbo GQY Video Telecom SHE:300076	-0.014x
Tivan Ltd AU:TVN	-0.023x
United Orthopedic TWO:4129	0.013x
Tatry Mountain Resorts a.s. PR:TMR	N/A
Vine Hill Capital Investment Corp. II Class A Ordinary Shares NASDAQ:VHCP	-0.001x
NexG Bhd KLSE:5216	0.072x

Annual Cash Flow Conversion Efficiency for Newron Pharmaceuticals SpA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Newron Pharmaceuticals SpA from 2005 to 2025. Review Newron Pharmaceuticals SpA (NWRN) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-11.13 Million ≈ $-14.07 Million	CHF32.56 Million ≈ $41.17 Million	-2.926x	+75.78%
2024-12-31	CHF1.46 Million ≈ $1.84 Million	CHF-17.61 Million ≈ $-22.27 Million	-12.081x	-3663.28%
2023-12-31	CHF-29.91 Million ≈ $-37.81 Million	CHF-10.14 Million ≈ $-12.82 Million	0.339x	-57.12%
2022-12-31	CHF-14.03 Million ≈ $-17.74 Million	CHF-11.09 Million ≈ $-14.02 Million	0.791x	+121.46%
2021-12-31	CHF3.11 Million ≈ $3.93 Million	CHF-11.45 Million ≈ $-14.47 Million	-3.684x	-307.54%
2020-12-31	CHF17.25 Million ≈ $21.80 Million	CHF-15.59 Million ≈ $-19.71 Million	-0.904x	-51.35%
2019-12-31	CHF36.80 Million ≈ $46.52 Million	CHF-21.98 Million ≈ $-27.78 Million	-0.597x	-105.27%
2018-12-31	CHF54.84 Million ≈ $69.33 Million	CHF-15.95 Million ≈ $-20.17 Million	-0.291x	-134.45%
2017-12-31	CHF67.72 Million ≈ $85.62 Million	CHF-8.40 Million ≈ $-10.62 Million	-0.124x	+68.48%
2016-12-31	CHF49.75 Million ≈ $62.89 Million	CHF-19.58 Million ≈ $-24.76 Million	-0.394x	-13.58%
2015-12-31	CHF37.11 Million ≈ $46.92 Million	CHF-12.86 Million ≈ $-16.26 Million	-0.347x	-1.43%
2014-12-31	CHF29.26 Million ≈ $36.99 Million	CHF-10.00 Million ≈ $-12.64 Million	-0.342x	+32.56%
2013-12-31	CHF21.09 Million ≈ $26.66 Million	CHF-10.69 Million ≈ $-13.51 Million	-0.507x	-340.15%
2012-12-31	CHF27.61 Million ≈ $34.90 Million	CHF5.83 Million ≈ $7.36 Million	0.211x	+128.11%
2011-12-31	CHF6.58 Million ≈ $8.33 Million	CHF-4.94 Million ≈ $-6.25 Million	-0.750x	+52.17%
2010-12-31	CHF12.19 Million ≈ $15.41 Million	CHF-19.13 Million ≈ $-24.18 Million	-1.569x	-99.27%
2009-12-31	CHF29.28 Million ≈ $37.02 Million	CHF-23.06 Million ≈ $-29.15 Million	-0.787x	-80.96%
2008-12-31	CHF45.81 Million ≈ $57.92 Million	CHF-19.93 Million ≈ $-25.20 Million	-0.435x	-80.11%
2007-12-31	CHF57.40 Million ≈ $72.57 Million	CHF-13.87 Million ≈ $-17.53 Million	-0.242x	-70.22%
2006-12-31	CHF67.86 Million ≈ $85.79 Million	CHF-9.63 Million ≈ $-12.17 Million	-0.142x	+83.14%
2005-12-31	CHF17.02 Million ≈ $21.52 Million	CHF-14.33 Million ≈ $-18.12 Million	-0.842x	--

About Newron Pharmaceuticals SpA

SW:NWRN Switzerland Biotechnology

Market Cap

$232.53 Million

CHF183.92 Million CHF

Market Cap Rank

#15779 Global

#170 in Switzerland

Share Price

CHF8.84

Change (1 day)

-1.78%

52-Week Range

CHF7.21 - CHF30.40

All Time High

CHF30.40